Prophylaxis and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers;Prophylaxe und behandlung von postoperativer übelkeit und erbrechen mit 5-HT3-rezeptorenblockern

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 31, Issue 4, 1996, Pages 200-204

  Alon, E ^a   Biro, P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DOLASETRON MESILATE; GRANISETRON; ONDANSETRON; SEROTONIN 3 ANTAGONIST; TROPISETRON;

DRUG EFFICACY; DRUG RESEARCH; HUMAN; NAUSEA; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; REVIEW; VOMITING;

ANTIEMETICS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANISETRON; HUMANS; INDOLES; INFUSIONS, INTRAVENOUS; NAUSEA; ONDANSETRON; POSTOPERATIVE COMPLICATIONS; QUINOLIZINES; SEROTONIN ANTAGONISTS; VOMITING;

EID: 0029894739     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995902     Document Type: Article

References (47)

1. Klockgether-Radke A, Feldmann M, Braun U, Muhlendyck H: Droperidol versus Metoclopramid. Anaesthesist 1992;41:254-259.
2. Kauste A, Tuominen M, Heikkinen H, Gordin A, Korttila K: Droperidol, alizapride and metoclopramide in the prevention and treatment of postoperative emetic sequelae. Eur. J. Anaesthesiol. 1986;3:1-9.
3. van Wijk MG, Smalhout B: A postoperative analysis of the patient's view of anaesthesia in a Netherlands' teaching hospital. Anaesthesia 1990;45:679-682.
4. Quinn A, Brown JH, Wallace PG, Asbury AJ: Studies in postoperative sequelae. Nausea and vomiting - still a problem. Anaesthesia 1994;49:62-65.
5. Cohen MM, Duncan PG, DeBoer DP, Tweed WA: The postoperative interview: assessing risk factors for nausea and vomiting. Anesth. Analg. 1994;78:7-16.
6. Andrews PLR: Physiology of nausea and vomiting. Brit. J. Anaesth. 1992;69:(Suppl.)24-29.
7. Naylor RJ, Inall FC: The physiology and pharmacology of postoperative nausea and vomiting. Anaesthesia 1994;49:(Suppl.)2-5.
8. Watcha MF, White PF: Postoperative nausea and vomiting. Anesthesiology 1992;77:162-184.
9. Waldvogel HH: Antiemetische Therapie. Nausea und Emesis. Thieme, Stuttgart, New York, 1995.
10. 3-antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Brit. J. Pharmacol. 1989;97:247-255.
11. Gunning S, Hagan RM, Tyers MB: Cisplatin induces biochemical and histological changes in the small intestine of the ferret. Brit. J. Pharmacol. 1987;90:135P.
12. 3 receptor antagonists. Oncology 1992;49:263-268.
13. Freeman AJ, Cunningham KT, Tyers MB: Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action. Anti-Cancer Drugs 1992;3:79-85.
14. 3-receptor antagonists the same? Eur. J. Cancer. 1992;28A:(Suppl.)S2-S6.
15. Boxenbaum H, Gillespie T, Heck K, Habne W.: Human dolasetron pharmacokinetics: I Absorbtion and disposition following single-dose oral administration to normal male subjects. Biopharmaceutics & Drug Disposition 1992;13:693-701.
16. Boxenbaum H, Gillespie T, Heck K, Hahne W: Human dolasetron pharmacokinetics: II Absorption and disposition following single-dose oral administration to normal male subjects. Biopharmaceutics & Drug Disposition 1993;14:131-141.
17. Kapur PA: Multicenter study versus nausea outcomes: the value of large numbers and the limitations. Anesth. Analg. 1994;78:5-6.
18. McKenzie R, Sharifi-zad S, Dershwitz M et al: A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients. J. Clin. Anesth. 1993;5:30-36.
19. Suen TKL, Gin TA, Chen PP, Rowpottom YM, Critchley LAH, Ray AK: Ondansetron 4 mg for the prevention of nausea and vomiting after minor laparoscopic gynaecological surgery: Anaesth. Intensive Care 1994;22:142-146.
20. Sung YF, Wetchler BV, Duncalf D, Joslyn AF: A double-blind, placebo-controlled pilot study examining the effectiveness of intravenous ondansetron in the prevention of postoperative nausea and emesis. J. Clin. Anesth. 1993;5:22-29.
21. Ummenhofer W, Frei FJ, Urwyler A, Kern C, Drewe J: Effects of ondansetron in the prevention of postoperative nausea and vomiting in children. Anesthesiology 1994;81:804-810.
22. Larijani GE, Gratz I, Afshar M, Minassian S: Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo. Anesth. Analg. 1991;73: 246-249.
23. Bodner M, White PF: Antiemetic efficacy after outpatient laparoscopy. Anesth. Analg. 1994;73:250-254.
24. Zomers PJW, Langenberg CJM, De Bruijn KM: Tropisetron for postoperative nausea and vomiting in patients after gynaecological surgery. Brit. J. Anaesth. 1993;71:677-680.
25. Alon E, Kocian R, Nett P, Koechil O, Baettig U, Grimaudo V: Double-blind comparison of tropisetron versus placebo in the prophylaxis of postoperative nausea and vomiting. Anesth. Analg. 1996;82:338-341.
26. Rohling R, Alon E, Atanassoff PG, Sailer H: Tropisetron versus metoclopramide and placebo for the prophylaxis of postoperative nausea and vomiting following maxillofacial surgery. Brit. J. Anaesth. 1995;74:A300.
27. Fujii Y, Tanaka H, Toyooka H: Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting. Can. J. Anaesth. 1994;41:794-797.
28. Fujit Y, Tanaka H, Toyooka H: Reduction of postoperative nausea and vomiting with granisetron. Can. J. Anaesth. 1994;41:291-294.
29. McKenzie R, Kovac A, O'Connor T, Duncalf D, Angel J, Gratz I, Tolpin E, McLeskey C, Joslyn A: Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993;78:21-28.
30. Khalil SN, Kataria B, Parson K et al: Ondansetron prevents postoperative nausea and vomiting in women outpatients. Anesth. Analg. 1994;79:845-851.
31. Mon E, Lenzlinger PM, Biro P, Atanassoff PG: Ondansetron 4 mg versus 8 mg in the prophylaxis of postoperative nausea and vomiting. Acta Anaesthesiol. Helv. 1994;1:15-20.
32. Heim C, Münzer T, Listyo R: Ondansetron versus Droperidol. Postoperanver therapeutischer Einsatz bei Nausea und Erbrechen. Anaesthesist 1994;43:504-509.
33. 3 antagonist ondansetron. Anesthesiology 1993;78: 15-20.
34. Helmers JH, Briggs L, Abrahamsson J, Soni J, Moodley J, Forrler M: A single i.v. dose of ondansetron 8 mg prior to induction of anaesthesia reduces vomiting in gynaecological patients. Can. J. Anaesth. 1993;40:1155-1161.
35. Diemunsch P, Wilson J, Chitour K, Patterson J, Kong KL: A double blind, parallel group, placebo controlled dose ranging study of i.v. granisetron in the prevention of postoperative nausea and vomiting (PONV). Anesthesiology 1994;81:(Suppl.)A1280.
36. Diemunsch P, Navé S, Meyerson LJ: Evaluation of the antiemetic properties of dolasetron mesilate in gynecological surgery. Brit. J. Anaesth. 1994;72:(Suppl. 1, A159)82.
37. Alon E, Biro P, Lenzlinger PM, Atanassoff PG: Ondansetron als Prophylaxe für postoperative Übelkeit und Erbrechen: eine prospektive, randomisierte Doppelblind- Vergleichsstudie mit Droperidol. Anaesthesist 1994;43:500-503.
38. Gan TJ, Collis R, Hetreed M: Double-blind comparison of ondansetron, dropendol and saline in the prevention of postoperative nausea and vomiting. Brit. J. Anaesth. 1994;72:544-547.
39. RaphaelJH, Norton AC: Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metclopramide. Brit. J. Anaesth. 1993;71:845-848.
40. Alon E, Himmelseher S: Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide. Anesth. Analg. 1992;75:561-565.
41. Kaufmann MA, Rosow C, Schnieper P, Schneider M: Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramid, and tropisetron. Anesth. Analg. 1994;78:988-994.
42. Arzneimittelkommission BGA: Arzneimittel-Schnellinformation: Extrapyramidalmotorische Störungen und ZNS- Reaktionen durch Ondansetron? Deutsches Ärzteblatt 1993;90:C880-C881.
43. Kris MG, Grunberg SM, Gralla RJ, Baltzer L, Zaretsky SA, Lifsey D, Tyson LB, Schmidt L, Hahne WF: Dose-ranging evaluation of the serotonin-antagonist dolasetron mesylate in patients receiving high-dose cisplatin. J. Clin. Oncol. 1994;12:1045-1049.
44. Watcha MF, Smith I: Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J. Clin. Anaesth. 1994;6:370-377.
45. Tryba M: Übelkeit und Erbrechen in der postoperativen Phasewelche Bedeutung haben neue Behandlungskonzepte? Anaesthesist 1994;43:491-493.
46. White PF, Watcha MF: Are new drugs cost-effecitve for patients undergoing ambulatory surgery. Anesthesiology 1993;78:2-5.
47. Bohrer H, Bach A, Martin E: Ondansetron - Ein neues anästhesie-relevantes Antiemetikum? Anaesthesiol. Reanim. 1994;19:11-13.